Skip to content
Solar Reels Daily

The Zimbabwean Government Rejects ‘Unbalanced’ US Healthcare Assistance Agreement Due to Data Concerns

Health funding image
The offered US financial assistance was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has rejected a major US health deal worth $367m (272 million pounds) spanning five years over the United States' insistence on sensitive biological samples.

The decision became public following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".

A government representative has since explained that the US was seeking health data for research and commercial purposes but was unwilling to guarantee the benefits from future vaccines.

"We are forced to start the difficult and regrettable task of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has urged further talks to reach a agreement agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.

Wider Background

This development follows a comparable situation in neighbouring Kenya, where a court halted a related deal with the US after legal challenges were filed about the security of citizens' health data.

After resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

The agency had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral agreements to boost transparency and responsibility.

According to statements, 16 African countries have so far signed these new agreements, constituting over $18.3bn in new funding.

Details of the Declined Agreement

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this partnership would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," Tremont said.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any corresponding guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.

"Effectively, our country would supply the basic resources for medical research without any assurance that the final treatments would be available to our citizens if a future health crisis arise."

National Interest and Global Health

He also noted that the American exit from the global health body and its pursuit of bilateral deals were undermining structures already established via the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage future global health emergencies.

"This system is intended to guarantee that when a country provides its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."

The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We welcome ongoing dialogue with our US partners on how subsequent co-operation might be arranged in a manner that honours the sovereignty and dignity of both nations."

Health Experts Reaction

Medical experts stated it understood the government's concerns, but recommended that talks should continue given that a large portion of the country's Aids initiatives relied on external financing.

"In cases where technical issues exist, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it commented.

The halted deal underscores the complex tensions between receiving much-needed foreign assistance and protecting a country's data in an increasingly data-driven world.

JW
Written by

Jamie Wilson

Renewable energy journalist with a decade of experience covering solar technology and sustainable living practices.

Solar Reels Daily

Type to search articles.